C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2004
11/25/2004	WO2004101520A1 Diarylmethylidene piperidine derivatives and their use as delta opiod receptor agonists
11/25/2004	WO2004101518A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
11/25/2004	WO2004101517A1 Carbazole derivative, organic semiconductor device, light-emitting device, and electronic device
11/25/2004	WO2004101512A2 Naphthyridine integrase inhibitors
11/25/2004	WO2004100949A2 Solid-state forms of 5-(difluoromethoxy)-2-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole (pantoprazole) sodium aqua complexes
11/25/2004	WO2004100946A1 1- (2h-pyrazol -3-yl) -3yl) {4-`1- (benzoyl) -piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhbitors of p38 kinase and/or tnf inhibitors for the treatment of imflammations
11/25/2004	WO2004100865A2 New benzimidazole derivatives
11/25/2004	WO2004089942A3 Benzimidazolidinone derivatives as muscarinic agents
11/25/2004	WO2004085385A3 Cannabinoid receptor ligands
11/25/2004	WO2004083174A3 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
11/25/2004	WO2004062629A3 Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells
11/25/2004	WO2004062609A3 Pyrimidine derivatives as il-8 receptor antagonists
11/25/2004	WO2004054498A3 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
11/25/2004	WO2004043379A3 Chemical compounds
11/25/2004	WO2004034972A3 Compounds, compositions, and methods
11/25/2004	WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
11/25/2004	US20040236114 1-[(hetero)aryloxy- or -thio-hydroxyalkyl]-substituted imidazole-4-carboxamides, e.g., 1-(5-(1,1'-biphenyl-3-yloxy)-2-hydroxy-3-pentyl]imidazole-4-carboxamide; treating rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis, sunburn, eczema, conjunctivitis, asthma, & bronchitis
11/25/2004	US20040236110 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
11/25/2004	US20040236109 Tetrahydroquinoline derivatives
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040236101 Heteroindanes a new class of potent cannabimimetic ligands
11/25/2004	US20040236084 2-Aminopyridine substituted heterocycles
11/25/2004	US20040235959 Insecticidal diamides
11/25/2004	US20040235930 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
11/25/2004	US20040235926 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders
11/25/2004	US20040235924 antidepressants; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches;drug addition; antiinflammatory agents
11/25/2004	US20040235904 Crystalline and amorphous solids of pantoprazole and processes for their preparation
11/25/2004	US20040235903 preparing a solution of esomeprazole salt in one or more solvents (methanol, ethanol, acetone, 2-butanone, ethyl acetate, chloroform) and recovering the salt of esomeprazole in the amorphous form from the solution by the removal of the solvent (distillation, evaporation spray drying, and freeze drying)
11/25/2004	US20040235897 3-[(1-benzyl-piperidin-4-yl)-(4-diethylcarbamoyl-phenyl)-amino]-benzamide used as opiod receptor agonists having improved pharmacokinetic, bioavailability, stability and/or lower toxicity; analgesisc; anxiolytic agents
11/25/2004	US20040235896 Certain azacycloalkyl substituted acetic acid derivatives
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235888 Utilities of amide compounds
11/25/2004	US20040235886 Gyrase inhibitors and uses thereof
11/25/2004	US20040235877 Novel use of tricyclic compound
11/25/2004	US20040235876 4,5-Disubstituted-2-aminopyrimidines
11/25/2004	US20040235870 Protein kinase inhibitors
11/25/2004	US20040235862 Protein kinase inhibitors
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235854 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
11/25/2004	US20040235849 For therapy and prophylaxis of states of pain
11/25/2004	US20040235848 Phenylalanine derivatives
11/25/2004	US20040235847 For therapy of thromboembolic and/or inflammatory disorders
11/25/2004	US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004	US20040235845 Use of phosphodiesterase iv inhibitors
11/25/2004	US20040235833 5-[(2R)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl) phenyl]ethyl}amino) propyl]-N-(2-methoxybenzyl)-1H-indole-2-carboxamide for example; asthma, bronchitis, and emphysema; beta-2 adrenergic receptor agonists
11/25/2004	US20040235832 Sexual diosrders; schizophrenia; drug abuse; eating disorders anxiolytic agents
11/25/2004	US20040235829 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/25/2004	US20040235828 For therapy and prophylaxis of thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, migraine, tumours, tumour diseases and/or tumour metastases
11/25/2004	US20040235826 Tyrosine kinase ihnibitors
11/25/2004	US20040235824 For the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses
11/25/2004	US20040235823 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235816 Administering compounds such as 1-benzhydryl-3-[(methylsulfonyl)(phenyl)methylene]azetidine for therapy of schizophrenia, Parkinson's disease, and Alzeimer's disease
11/25/2004	US20040235814 Administering compounds such as 1-[1-methylene-4-(bromo-methylene)phenylene]-4,8,11-tris(diethoxyphosphoryl-1,4,8,11-tetraazacyclotetra-decane to modulate a chemokine receptor
11/25/2004	US20040235753 Oxytocin agonists
11/25/2004	US20040235752 3-fluoro-pyrrolidines as antidiabetic agents
11/25/2004	US20040231558 Has a clear hue, high light fastness and high moisture resistance
11/25/2004	CA2528220A1 Indazole-derivatives as factor xa inhibitors
11/25/2004	CA2526066A1 New indole derivatives as factor xa inhibitors
11/25/2004	CA2526065A1 Benzimidazole-derivatives as factor xa inhibitors
11/25/2004	CA2525860A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004	CA2525858A1 Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
11/25/2004	CA2525849A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
11/25/2004	CA2525442A1 Cyanofluoropyrrolidine derivatives
11/25/2004	CA2524958A1 Isoquinoline derivatives and their use as gfat inhibitors
11/25/2004	CA2524434A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/25/2004	CA2523431A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
11/24/2004	EP1479737A1 Triarylsilyl(meth)acryloyl-containing polymers for marine coating compositions
11/24/2004	EP1479678A1 Pyrazole-derivatives as factor xa inhibitors
11/24/2004	EP1479676A1 Benzimidazole-derivatives as factor xa inhibitors
11/24/2004	EP1479675A1 Indazole-derivatives as factor Xa inhibitors
11/24/2004	EP1479674A1 Imidiazole-derivatives as factor xa inhibitors
11/24/2004	EP1479671A1 Pyrimidinone compounds
11/24/2004	EP1479670A1 Novel fused ring indazole compounds
11/24/2004	EP1479397A1 2,4,6-triamino-1,3,5-triazine derivative
11/24/2004	EP1479385A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
11/24/2004	EP1479384A1 Fibrosis inhibitor
11/24/2004	EP1479373A1 Hair growth compositions and uses
11/24/2004	EP1478643A1 5-heteroaryl substituted indoles
11/24/2004	EP1478628A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
11/24/2004	EP1478626A2 Guanidino compounds
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478437A1 Acc inhibitors
11/24/2004	EP1478382A1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096
11/24/2004	EP1478363A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
11/24/2004	EP1478359A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
11/24/2004	EP1411949A4 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
11/24/2004	EP1200406B1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor
11/24/2004	EP1033965B1 Agents and method for producing semi-permanent colorations of keratin fibers
11/24/2004	EP0976732B1 1,4-substituted cyclic amine derivatives
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549811A Ortho-substituted aryl amides for controlling invertebrate pests
11/24/2004	CN1549808A New mandelic acid derivatives and their use as thrombin inhibitors
11/24/2004	CN1549718A Use of compounds for treating conditions resulting from injury to the corneal nerve after LASIK and other ocular surgeries
11/24/2004	CN1549717A Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them
11/24/2004	CN1548436A Novel 2-alkyl substituted imidazole compounds
11/24/2004	CN1548435A Gatifloxacin hydrobride as quinolone compound and its prepn and application as antibacterial agent
11/24/2004	CN1548425A Substituted formamidetriazole
11/24/2004	CN1176915C Alkynyl phenyl heteroaromatic glucokinase activators

1 ... 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 ... 1080